C.P., R., D., B., P.W, S., & C.R., C. (1978). Reactions of Methamidophos with Mammalian Cholinesterase (Report No. DOT/FAA/AM-78/26). Civil Aerospace Medical Institute. https://rosap.ntl.bts.gov/view/dot/21136
C.P., Robinson, Beiergrohslein D., Smith P.W, and Crane C.R.. Reactions of Methamidophos with Mammalian Cholinesterase. Report no. DOT/FAA/AM-78/26. Civil Aerospace Medical Institute, 1978. https://rosap.ntl.bts.gov/view/dot/21136.
C.P., Robinson, et al. Reactions of Methamidophos with Mammalian Cholinesterase. Civil Aerospace Medical Institute, 1978, Report no. DOT/FAA/AM-78/26, ROSA P. https://rosap.ntl.bts.gov/view/dot/21136.
The lethality of methamidophos, a phosphoramidothioate, to rats (i.p. LD50, 15 mg/kg), is similar to that of such potent organophosphate compounds as parathion and paraoxon. Certain distinctive features of its chemical structure, and reported failure of cholinesterase inhibited with methamiodophos to reactivate spontaneously in insects, prompted this study of its reactions with mammalian cholinesterase to determine if the treatment of poisoning requires modification.
;
Atropine (10 mg/kg) or pralidoxime (60 mg/kg) afforded significant protection against lethality from methamidophos (LD50's, 60 + or - 0.4 and 52 + or - 4.9 mg/kg, respectively). Partial spontaneous recovery of inhibited cholinesterase activity was observed. However, a single dose of pralidoxime, given essentially simultaneously with methamidophos, did not hasten the recovery of cholinesterase activity.
C.P., R., D., B., P.W, S., & C.R., C. (1978). Reactions of Methamidophos with Mammalian Cholinesterase (Report No. DOT/FAA/AM-78/26). Civil Aerospace Medical Institute. https://rosap.ntl.bts.gov/view/dot/21136
C.P., Robinson, Beiergrohslein D., Smith P.W, and Crane C.R.. Reactions of Methamidophos with Mammalian Cholinesterase. Report no. DOT/FAA/AM-78/26. Civil Aerospace Medical Institute, 1978. https://rosap.ntl.bts.gov/view/dot/21136.
C.P., Robinson, et al. Reactions of Methamidophos with Mammalian Cholinesterase. Civil Aerospace Medical Institute, 1978, Report no. DOT/FAA/AM-78/26, ROSA P. https://rosap.ntl.bts.gov/view/dot/21136.
ROSA P serves as an archival repository of USDOT-published products including scientific
findings, journal articles, guidelines, recommendations, or other information authored or co-authored by
USDOT or funded partners. As a repository, ROSA P retains documents in their original published format to
ensure public access to scientific information.
Links with this icon indicate that you are leaving a Bureau of Transportation
Statistics (BTS)/National Transportation Library (NTL)
Web-based service.
Thank you for visiting.
You are about to access a non-government link outside of
the U.S. Department of Transportation's National
Transportation Library.
Please note: While links to Web sites outside of DOT are
offered for your convenience, when you exit DOT Web sites,
Federal privacy policy and Section 508 of the Rehabilitation
Act (accessibility requirements) no longer apply. In
addition, DOT does not attest to the accuracy, relevance,
timeliness or completeness of information provided by linked
sites. Linking to a Web site does not constitute an
endorsement by DOT of the sponsors of the site or the
products presented on the site. For more information, please
view DOT's Web site linking policy.
To get back to the page you were previously viewing, click
your Cancel button.